Gryaznov Sergei bought MAIA
June 1, 2026 · Form 4 insider transaction
Gryaznov Sergei bought 2,000 shares of MAIA Biotechnology, Inc. at $1.34 per share, a transaction worth $2.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,000
Price
$1.34
Total value
$2.7K
InsiderGryaznov Sergei
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 1, 2026
Filing dateJune 2, 2026
Shares owned after46,511
OwnershipDirect
10b5-1 planNo
AmendedNo